Inflammatory reactions of the intestinal tract are the result of a combination of hereditary, genetic and/or environmental factors that have been clustered in the inflammatory bowel disease (IBD). ReadyCell has available CacoReady and CacoGoblet to assay compounds inflammatory properties.
A new drug against malignant cells was found using methods such as High Throughput Screening (HTS) and Caco-2 permeability assay with CacoReady plates.
We want to send you our greetings and best wishes for the holiday season! This year, artists from the art studio of the AMPANS Foundation created a special Christmas card.
The Drug Discovery Summit (DDS) includes high-level national and international speakers, interactive roundtables, knowledge-sharing panel sessions, workshops and networking.
The U.S. company Adari Cell Science met with ReadyCell at the Parc Científic de Barcelona and shared their impressions of the past year.
